Our mission is to improve the care of rare liver disease patients throughout Europe

A click on the button will establish a connection to YouTube.
This may result in YouTube being able to collect personal information.
Please refer to our Privacy notice for further information.

General Covid update and the impact on rare liver disease patients

Both the covid pandemic and the prospect of new vaccines have changed the general situation significantly in recent weeks. For patients with rare liver diseases, the situation is much more complicated and the questions even more specific.

New Hepatic Alveolar Echinococcosis Working Group

Alveolar Echinococcosis (AE) is a rare parasitic disease caused by the infection with the larval stage of the Echinococcus multilocularis tapeworm, known to be endemic in the northern hemisphere, mainly in central Europe and western China.

1st International Workshop on Future Therapies in Autoimmune Hepatitis

Friutfull 1st International Workshop on Future Therapies in Autoimmune Hepatitis with experts from various different scientific fields. The outstanding success of this workshop was the cooperation not only of clinicians but also of biostatisticians, patient advocates and medical officers from the FDA.

Clinical exchange program – time for a review

The European Commission in cooperation with ECORYS, one of the oldest economic research and consulting companies in Europe, had launched a Clinical Exchange Program to share knowledge and stimulate collaborations between healthcare professionals within the ERNs.

Scientific News